ondansetron

Product NDC
53002-0600
11-digit product format
530020600
Labeler code
53002
Product ID
53002-0600_5f3aa8c9-1704-42ab-ac93-4684c6a84446
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ondansetron hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA077851
Marketing category
ANDA
Marketing start
2007-06-25
Marketing end
0000-00-00
Substance
ONDANSETRON HYDROCHLORIDE
Active strength
8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d9bd4853-037c-6968-f4d4-9bb9a0efd1eaProduct name220250722
32e23bc9-ce14-4555-bb6d-bcb654d7d296Product name120201015
e459f50a-1553-4aab-b6bd-1e5f0c211c49Product name120201015
909480fe-0d18-c1c1-a658-0bd9a7131822Product name520170829

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53002-0600-12025-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-22025-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-32025-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-42025-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-12023-06-08C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-22023-06-08C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-32023-06-08C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-42023-06-08C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-12023-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-22023-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-32023-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-42023-01-30C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-12020-12-15C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-22020-12-15C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-32020-12-15C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-42020-12-15C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-12020-01-31C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-22020-01-31C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-32020-01-31C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632
53002-0600-42020-01-31C16284748780-19d75b9d0-c6c4-f424-e053-dadaa90a57ce079fdfb4-8007-4f5a-a8fa-4b72c3748632

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53002-0600-1ondansetron3 in 1 BOTTLETABLET, FILM COATED35
53002-0600-2ondansetron6 in 1 BOTTLETABLET, FILM COATED65
53002-0600-3ondansetron10 in 1 BOTTLETABLET, FILM COATED105
53002-0600-4ondansetron30 in 1 BOTTLETABLET, FILM COATED305

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53002-0600ONDANSETRON (ONDANSETRON HYDROCHLORIDE) TABLET, FILM COATED [RPK PHARMACEUTICALS, INC.]5Legacy NDC, 4 package rows20230609_079fdfb4-8007-4f5a-a8fa-4b72c3748632.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312086ondansetron HCl 8 MG Oral TabletPSN079fdfb4-8007-4f5a-a8fa-4b72c37486325
312086ondansetron 8 MG Oral TabletSCD079fdfb4-8007-4f5a-a8fa-4b72c37486325
312086ondansetron 8 MG (as ondansetron HCl dihydrate 10 MG) Oral TabletSY079fdfb4-8007-4f5a-a8fa-4b72c37486325

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
53002-0600-1530020600013 TABLET, FILM COATED in 1 BOTTLE (53002-0600-1) 2017-10-010000-00-00NoNoCurrent
53002-0600-2530020600026 TABLET, FILM COATED in 1 BOTTLE (53002-0600-2) 2017-10-010000-00-00NoNoCurrent
53002-0600-35300206000310 TABLET, FILM COATED in 1 BOTTLE (53002-0600-3) 2017-10-010000-00-00NoNoCurrent
53002-0600-45300206000430 TABLET, FILM COATED in 1 BOTTLE (53002-0600-4) 2017-10-010000-00-00NoNoCurrent